Dentium has launched ‘Collagen Graft x2D,’ a new collagen matrix for soft tissue augmentation. The new product boasts double the density of its predecessor, Collagen Graft x1D (formerly Collagen Graft 2), providing significantly enhanced tensile and suture strength. This design makes it optimally suited for the handling requirements of the open healing technique.

‘Collagen Graft x2D’ maintains its volume after hydration with no change in thickness, ensuring exceptional dimensional stability. This feature facilitates easier tissue fixation and suturing, greatly enhancing procedural convenience for the clinician. At the KAOMI 2025 Summer Special Lecture on July 5th, clinical findings were presented that highlighted the product's excellent soft tissue healing outcomes in open-healing socket preservation cases.

According to Dentium, ‘Collagen Graft x2D’ is versatile enough for a wide range of applications, including soft tissue augmentation, root coverage procedures, and as an alternative to connective tissue grafts (CTG). With this launch, Dentium aims to set a new standard in soft tissue management and will continue to expand the product's clinical applications.

Dentium has consistently delivered streamlined and effective bone and soft tissue augmentation solutions under its ‘Easy Bone Graft’ concept. Building on this philosophy, the company will host the ‘Easy Bone Graft Consensus’ on November 16th at the COEX Auditorium in Seoul. The conference will serve as a forum for discussing the standardization of bone and soft tissue augmentation procedures.

The seminar will delve into key challenges faced by clinicians, covering precise criteria for procedural selection, minimally invasive approaches, and definitive application techniques for essential clinical scenarios. The event will feature a panel of nine distinguished speakers, including university faculty and leading private practitioners, who will present lectures based on the latest clinical evidence. The goal is to establish simpler, more predictable clinical protocols for everyday practice.

Through this consensus, Dentium aims to reinforce its role as a collaborative partner in establishing new clinical standards, going beyond simply supplying products. A representative from Dentium stated, "We will continue to deliver innovative products and clinical guidance that reflect real-world clinical needs. Under our slogan, ‘Making Great Products Widely Used,’ our focus remains on providing clinicians with simpler, more efficient treatment solutions and offering patients better long-term outcomes."